Shares of Elanco Animal Health Inc (ELAN) surged 5.00% during intraday trading on Wednesday, marking a significant upward movement for the animal health company.
The sharp rise appears to be driven by a wave of positive analyst actions published throughout the trading session. Multiple financial institutions issued research notes reiterating or affirming bullish stances on the stock, boosting investor sentiment.
Notably, BofA raised its price target on Elanco to $30 from $28 while maintaining a Buy rating. Other firms including Jefferies, KeyBanc, and Bank of America Securities also reaffirmed their Buy or equivalent ratings on the company, contributing to the positive momentum in the stock price.